Archive for 'Cell therapy'

100th spin-off of the University of Liège, SYNOLYNE SA (Liège, Belgium), develops patented chitosan-based hydrogel to wipe out arthritis.

100th spin-off of the University of Liège, SYNOLYNE SA (Liège, Belgium), develops patented chitosan-based hydrogel to wipe out arthritis.

SYNOLYNE SA, the new spin-off of Liège University and spin-out of Kitozyme SA, is specialized in the research, development and marketing of a chitosan-based hydrogel with mechanical and biological properties designed to protect the cartilage and [...]

Prestigious international stem cell award (ISSCR) is granted to Belgian Dr. Cédric Blanpain (FNRS-ULB/WELBIO).

Prestigious international stem cell award (ISSCR) is granted to Belgian Dr. Cédric Blanpain (FNRS-ULB/WELBIO).

The ISSCR (International Society of Stem Cell Research), an organization bringing together top specialists worldwide, has named Dr. Cédric Blanpain as the recipient of the fourth annual ISSCR-University of Pittsburgh Outstanding Young Investigator Award. For the first time, [...]

iTeos Therapeutics (Gosselies, Belgium), kicks-off to develop innovative immunotherapy compounds in an effort to cure certain cancers.

iTeos Therapeutics (Gosselies, Belgium), kicks-off to develop innovative immunotherapy compounds in an effort to cure certain cancers.

The birth of a Belgian company, a joint spin-off of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute of the Université catholique de Louvain (UCL), focusing on new drug discovery, has been made [...]

Promethera Biosciences of Belgium attracts international investors allowing promising future for treatment of liver disease.

Promethera Biosciences of Belgium attracts international investors allowing promising future for treatment of liver disease.

UCL spin off biotechnology company Promethera Biosciences (Mont-Saint Guibert, Wallonia/Belgium), with the help and support of pharmaceutical groups and investors worldwide, is targeting a medical breakthrough with an innovative therapeutic cell product designed to treat liver [...]

Cardio3 BioSciences and ATMI, Inc. Sign a Letter of Intent

Cardio3 BioSciences and ATMI, Inc. Sign a Letter of Intent

Cardio3 BioSciences, a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases announced today, that it has signed a Letter of Intent with Advanced Technology Materials, Inc. (“ATMI”), a [...]

The European Diagnostic Clusters Alliance (EDCA) starts up

The European Diagnostic Clusters Alliance (EDCA) starts up

The eight European clusters that announced their intention to join forces to drive medical diagnostics in Europe have formalized this alliance with the signing of its bylaws on 30 June in Brussels. For the next three [...]

Innovative Company in Cell Therapy will Bring Good Science to Gosselies, Belgium

Innovative Company in Cell Therapy will Bring Good Science to Gosselies, Belgium

MaStherCell incorporation : a step forward to industrialization of cell therapy in Europe Gosselies, Belgium, November 4, 2011 : Boosted by the Wallonia government authorities and Biowin, MaStherCell , an innovative cGMP contract manufacturing platform, just [...]